Home > Boards > US Listed > Telecommunications Hardware > OptimizeRx Corporation (OPRX)

Very poor performance during the last few quarters.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
4retire Member Profile
 
Followed By 20
Posts 3,063
Boards Moderated 0
Alias Born 02/18/13
160x600 placeholder
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/14/2021 1:30:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/13/2021 4:15:49 PM
OptimizeRx Named to Financial Times ―The Americas’ Fastest-Growing Companies List for the Second Consecutive Year GlobeNewswire Inc. - 4/13/2021 7:51:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 12:44:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 12:41:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 12:34:24 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/29/2021 4:16:42 PM
OptimizeRX Will Continue To Thrive Post-Pandemic TipRanks - 3/22/2021 9:25:47 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/17/2021 11:13:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/16/2021 4:16:10 PM
OptimizeRx nabs 19 new enterprise-level engagements in Q1 leading to recurring revenue Seeking Alpha - 3/16/2021 7:53:29 AM
OptimizeRx Recurring Revenue Grows as it Secures 19 New Enterprise-Level Engagements in Q1 2021 GlobeNewswire Inc. - 3/16/2021 7:30:00 AM
OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 GlobeNewswire Inc. - 3/3/2021 7:31:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2021 9:05:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 8:46:55 AM
OptimizeRx EPS beats by $0.01, beats on revenue Seeking Alpha - 2/24/2021 4:06:17 PM
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share GlobeNewswire Inc. - 2/24/2021 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/23/2021 11:15:02 AM
OptimizeRx’s Angelo Campano Named to MM+M 40 Under 40 List GlobeNewswire Inc. - 2/23/2021 7:31:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/18/2021 4:16:40 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 2/18/2021 1:06:39 PM
OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ET GlobeNewswire Inc. - 2/18/2021 7:31:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:33:19 PM
OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021 GlobeNewswire Inc. - 2/16/2021 7:31:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/12/2021 5:15:24 PM
4retire   Monday, 11/07/16 11:57:48 PM
Re: None
Post # of 331 
Very poor performance during the last few quarters. Expenses continue to increase with the hiring of professionals to ramp up sales. Only problem is that sales were basically flat.

OPRX continues to try and reinvent itself over the last few years. As a long time shareholder I must say that it is very frustrating to hold on to this stock when "true profitability is just around the corner."

Sorry, that's my vent until next quarter's report card.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences